Compare Enveric Biosciences Inc (ENVB) vs Zscaler Inc (ZS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Zscaler Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Zscaler Inc trades at $176.9 (market cap $28.87B). The key difference: Zscaler Inc is far larger — about 4656.5× Enveric Biosciences Inc's market cap, and Zscaler Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | ZS | |
|---|---|---|
Market Cap | $6.20M | $28.87B |
Sector | Health | Technology |
52-Week High | $17.40 | $336.27 |
52-Week Low | $1.27 | $118.05 |
Enterprise Value | $1.30M | $27.20B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Zscaler Inc
Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →
